文献
J-GLOBAL ID:201802268430114258
整理番号:18A0256804
リオシグアト:肺高血圧症における作用と臨床開発のモード【Powered by NICT】
Riociguat: Mode of Action and Clinical Development in Pulmonary Hypertension
著者 (8件):
Ghofrani Hossein-Ardeschir
(University of Giessen and Marburg Lung Center, Giessen, Germany and the German Center for Lung Research (DZL))
,
Ghofrani Hossein-Ardeschir
(Department of Medicine, Imperial College London, London, England)
,
Humbert Marc
(Assistance Publique-Hopitaux de Paris, Service de Pneumologie, DHU Thorax Innovation, Hopital Bicetre and Universite Paris-Sud, Laboratoire d’Excellence en Recherche sur le Medicament et Innovation Therapeutique and INSERM Unite 999, Le Kremlin-Bicetre, France)
,
Langleben David
(Center for Pulmonary Vascular Disease and Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, Canada)
,
Schermuly Ralph
(University of Giessen and Marburg Lung Center, Giessen, Germany and the German Center for Lung Research (DZL))
,
Stasch Johannes-Peter
(Bayer Pharma AG, Wuppertal and University Halle, Institute of Pharmacy, Halle (Saale), Germany)
,
Wilkins Martin R.
(Department of Medicine, Imperial College London, London, England)
,
Klinger James R.
(Division of Pulmonary, Sleep, and Critical Care Medicine, Rhode Island Hospital, Alpert Medical School of Brown University, Providence, RI)
資料名:
Chest
(Chest)
巻:
151
号:
2
ページ:
468-480
発行年:
2017年
JST資料番号:
D0800B
ISSN:
0012-3692
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)